
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Androgen Receptor Roles in the Development of Benign Prostate Hyperplasia
Kouji Izumi, Atsushi Mizokami, Wen‐Jye Lin, et al.
American Journal Of Pathology (2013) Vol. 182, Iss. 6, pp. 1942-1949
Open Access | Times Cited: 141
Kouji Izumi, Atsushi Mizokami, Wen‐Jye Lin, et al.
American Journal Of Pathology (2013) Vol. 182, Iss. 6, pp. 1942-1949
Open Access | Times Cited: 141
Showing 51-75 of 141 citing articles:
Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia
Raman Krishnamoorthi, Anand Ganapathy A, Vijayakumari Mahadevan Hari Priya, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118207-118207
Closed Access | Times Cited: 2
Raman Krishnamoorthi, Anand Ganapathy A, Vijayakumari Mahadevan Hari Priya, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118207-118207
Closed Access | Times Cited: 2
Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9®to better battle prostate cancer progression
Kouji Izumi, Chawnshang Chang
OncoImmunology (2013) Vol. 2, Iss. 12, pp. e26853-e26853
Open Access | Times Cited: 20
Kouji Izumi, Chawnshang Chang
OncoImmunology (2013) Vol. 2, Iss. 12, pp. e26853-e26853
Open Access | Times Cited: 20
Hexane fraction of Annona muricata (Sour sop) seed ameliorates testosterone-induced benign prostatic hyperplasia in rats
Oluwatosin A. Adaramoye, Taiwo Dorcas Oladipo, Olubukola O. Akanni, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 111, pp. 403-413
Open Access | Times Cited: 20
Oluwatosin A. Adaramoye, Taiwo Dorcas Oladipo, Olubukola O. Akanni, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 111, pp. 403-413
Open Access | Times Cited: 20
Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status
Wararut Buncharoen, Kanokporn Saenphet, Supap Saenphet, et al.
Journal of Ethnopharmacology (2016) Vol. 194, pp. 483-494
Closed Access | Times Cited: 19
Wararut Buncharoen, Kanokporn Saenphet, Supap Saenphet, et al.
Journal of Ethnopharmacology (2016) Vol. 194, pp. 483-494
Closed Access | Times Cited: 19
CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway
Yang Yang, Shuai Hu, Jie Liu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Yang Yang, Shuai Hu, Jie Liu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 19
Androgen replacement therapy for cancer‐related symptoms in male: result of prospective randomized trial (ARTFORM study)
Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 4, pp. 831-842
Open Access | Times Cited: 15
Kouji Izumi, Hiroaki Iwamoto, Hiroshi Yaegashi, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 4, pp. 831-842
Open Access | Times Cited: 15
Targeting the Lnc-OPHN1-5/androgen receptor/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression
Meng Zhang, Yin Sun, Chi‐Ping Huang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 15
Meng Zhang, Yin Sun, Chi‐Ping Huang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 10
Open Access | Times Cited: 15
Cinnamomum cassia and Rosa laevigata Mixture Improves Benign Prostatic Hyperplasia in Rats by Regulating Androgen Receptor Signaling and Apoptosis
Myung-Hee Kim, Phuong Tran, Jun Yin, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 818-818
Open Access | Times Cited: 6
Myung-Hee Kim, Phuong Tran, Jun Yin, et al.
Nutrients (2023) Vol. 15, Iss. 4, pp. 818-818
Open Access | Times Cited: 6
The biological and clinical advances of androgen receptor function in age-related diseases and cancer [Review]
Ken‐ichi Takayama
Endocrine Journal (2017) Vol. 64, Iss. 10, pp. 933-946
Open Access | Times Cited: 17
Ken‐ichi Takayama
Endocrine Journal (2017) Vol. 64, Iss. 10, pp. 933-946
Open Access | Times Cited: 17
The therapeutic effects of Stauntonia hexaphylla in benign prostate hyperplasia are mediated by the regulation of androgen receptors and 5α-reductase type 2
Geum-Lan Hong, Se-Ra Park, Da-Young Jung, et al.
Journal of Ethnopharmacology (2019) Vol. 250, pp. 112446-112446
Closed Access | Times Cited: 17
Geum-Lan Hong, Se-Ra Park, Da-Young Jung, et al.
Journal of Ethnopharmacology (2019) Vol. 250, pp. 112446-112446
Closed Access | Times Cited: 17
Effects of Lespedeza Cuneata aqueous extract on testosterone-induced prostatic hyperplasia
Bong Kyun Park, Chang Won Kim, Jeong Eun Kwon, et al.
Pharmaceutical Biology (2019) Vol. 57, Iss. 1, pp. 89-97
Open Access | Times Cited: 16
Bong Kyun Park, Chang Won Kim, Jeong Eun Kwon, et al.
Pharmaceutical Biology (2019) Vol. 57, Iss. 1, pp. 89-97
Open Access | Times Cited: 16
Peanut Sprout Extracts Cultivated with Fermented Sawdust Medium Inhibits Benign Prostatic Hyperplasia In Vitro and In Vivo
Junhui Song, Byung‐Doo Hwang, Hyun Joo Chung, et al.
The World Journal of Men s Health (2020) Vol. 38, Iss. 3, pp. 385-385
Open Access | Times Cited: 16
Junhui Song, Byung‐Doo Hwang, Hyun Joo Chung, et al.
The World Journal of Men s Health (2020) Vol. 38, Iss. 3, pp. 385-385
Open Access | Times Cited: 16
Protective effects of combination of Stauntonia hexaphylla and Cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5α- reductase type 2 and induced cell apoptosis
Shanika Karunasagara, Geum-Lan Hong, Da-Young Jung, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0236879-e0236879
Open Access | Times Cited: 16
Shanika Karunasagara, Geum-Lan Hong, Da-Young Jung, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0236879-e0236879
Open Access | Times Cited: 16
Inflammatory pathway employed by Red Maca to treat induced benign prostatic hyperplasia in rats
Cinthya Vásquez‐Velásquez, Manuel Gasco, Diego Fano-Sizgorich, et al.
Andrologia (2020) Vol. 52, Iss. 3
Open Access | Times Cited: 15
Cinthya Vásquez‐Velásquez, Manuel Gasco, Diego Fano-Sizgorich, et al.
Andrologia (2020) Vol. 52, Iss. 3
Open Access | Times Cited: 15
Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects
Haifa Almukadi, Basma G. Eid, Rasheed A. Shaik, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112199-112199
Open Access | Times Cited: 14
Haifa Almukadi, Basma G. Eid, Rasheed A. Shaik, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112199-112199
Open Access | Times Cited: 14
ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling
Hao Tian, Fu-Ju Chou, Jing Tian, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 13
Hao Tian, Fu-Ju Chou, Jing Tian, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 13
GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition
Yejin Kim, Da Young Lee, Hyejung Jo, et al.
Aging (2021) Vol. 13, Iss. 3, pp. 3202-3217
Open Access | Times Cited: 13
Yejin Kim, Da Young Lee, Hyejung Jo, et al.
Aging (2021) Vol. 13, Iss. 3, pp. 3202-3217
Open Access | Times Cited: 13
Stimulation of prostate cells by the senescence phenotype of epithelial and stromal cells: Implication for benign prostate hyperplasia
Shoulei Jiang, Chung S. Song, Bandana Chatterjee
FASEB BioAdvances (2019)
Open Access | Times Cited: 15
Shoulei Jiang, Chung S. Song, Bandana Chatterjee
FASEB BioAdvances (2019)
Open Access | Times Cited: 15
Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia
Fei Wu, Sentai Ding, Xin Li, et al.
Oncotarget (2016) Vol. 7, Iss. 11, pp. 12053-12062
Open Access | Times Cited: 14
Fei Wu, Sentai Ding, Xin Li, et al.
Oncotarget (2016) Vol. 7, Iss. 11, pp. 12053-12062
Open Access | Times Cited: 14
Anti-Proliferation Effects of Garlic (Allium sativum L.) on the Progression of Benign Prostatic Hyperplasia
Kyung‐Sook Chung, Su‐Jin Shin, Na Young Lee, et al.
Phytotherapy Research (2016) Vol. 30, Iss. 7, pp. 1197-1203
Closed Access | Times Cited: 14
Kyung‐Sook Chung, Su‐Jin Shin, Na Young Lee, et al.
Phytotherapy Research (2016) Vol. 30, Iss. 7, pp. 1197-1203
Closed Access | Times Cited: 14
N-Butanol and Aqueous Fractions of Red Maca Methanolic Extract Exerts Opposite Effects on Androgen and Oestrogens Receptors (Alpha and Beta) in Rats with Testosterone-Induced Benign Prostatic Hyperplasia
Diego Fano-Sizgorich, Cinthya Vásquez‐Velásquez, Cynthia Gonzales‐Castañeda, et al.
Evidence-based Complementary and Alternative Medicine (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 13
Diego Fano-Sizgorich, Cinthya Vásquez‐Velásquez, Cynthia Gonzales‐Castañeda, et al.
Evidence-based Complementary and Alternative Medicine (2017) Vol. 2017, Iss. 1
Open Access | Times Cited: 13
Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia
Bo‐Ram Jin, Hyo-Jung Kim, Sang-Kyun Park, et al.
Molecules (2018) Vol. 23, Iss. 10, pp. 2638-2638
Open Access | Times Cited: 13
Bo‐Ram Jin, Hyo-Jung Kim, Sang-Kyun Park, et al.
Molecules (2018) Vol. 23, Iss. 10, pp. 2638-2638
Open Access | Times Cited: 13
6′-Sialyllactose Ameliorates In Vivo and In Vitro Benign Prostatic Hyperplasia by Regulating the E2F1/pRb–AR Pathway
Bo‐Ram Jin, Hyo-Jung Kim, Eun-Yeong Kim, et al.
Nutrients (2019) Vol. 11, Iss. 9, pp. 2203-2203
Open Access | Times Cited: 12
Bo‐Ram Jin, Hyo-Jung Kim, Eun-Yeong Kim, et al.
Nutrients (2019) Vol. 11, Iss. 9, pp. 2203-2203
Open Access | Times Cited: 12
Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways
Eman M. Elbaz, Hebat Allah A. Amin, Ahmed S. Kamel, et al.
Inflammopharmacology (2020) Vol. 28, Iss. 5, pp. 1407-1420
Closed Access | Times Cited: 12
Eman M. Elbaz, Hebat Allah A. Amin, Ahmed S. Kamel, et al.
Inflammopharmacology (2020) Vol. 28, Iss. 5, pp. 1407-1420
Closed Access | Times Cited: 12
Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats
Mona A. Kortam, Asmaa S. Alawady, Nermin Abdel Hamid Sadik, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 723, pp. 109237-109237
Closed Access | Times Cited: 8
Mona A. Kortam, Asmaa S. Alawady, Nermin Abdel Hamid Sadik, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 723, pp. 109237-109237
Closed Access | Times Cited: 8